rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ
Figure 2
rAAV-mediated gene transfer in primary human chondrosarcoma in situ. Human chondrosarcoma explant cultures were transduced with rAAV-RFP or rAAV-lacZ (20 or 40 μL) and processed to monitor transgene expression 20 days after vector application by X-Gal staining (a) and for immunodetection of β-gal activity ((b) magnification ×20).